M1 Kliniken AG (MKLNF)
11.73
0.00 (0.00%)
USD |
OTCM |
May 21, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 220.24M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 5.03% |
| Valuation | |
| PE Ratio | 8.722 |
| PE Ratio (Forward) | |
| PS Ratio | 0.5291 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 1.392 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 2.14% |
Profile
| M1 Kliniken AG engages in the provision of medical services in the field of beauty sector. It operates through the Beauty and Trade segments. The Beauty segment focuses on medical-aesthetic beauty treatments and operations as well as the operation and provision of medical infrastructures for partner companies. The Trade segment sells pharmaceuticals and medical products in the cost-intensive therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was founded in 2007 and is headquartered in Berlin, Germany. |
| URL | http://www.m1-kliniken.de |
| Investor Relations URL | N/A |
| HQ State/Province | Berlin |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | Jul. 13, 2026 |
| Last Ex-Dividend Date | Jul. 18, 2025 |
Profile
| M1 Kliniken AG engages in the provision of medical services in the field of beauty sector. It operates through the Beauty and Trade segments. The Beauty segment focuses on medical-aesthetic beauty treatments and operations as well as the operation and provision of medical infrastructures for partner companies. The Trade segment sells pharmaceuticals and medical products in the cost-intensive therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was founded in 2007 and is headquartered in Berlin, Germany. |
| URL | http://www.m1-kliniken.de |
| Investor Relations URL | N/A |
| HQ State/Province | Berlin |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | Jul. 13, 2026 |
| Last Ex-Dividend Date | Jul. 18, 2025 |